Convergence Investment Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,760
Closed -$1.34M 257
2024
Q4
$1.34M Buy
5,760
+717
+14% +$165K 0.3% 120
2024
Q3
$1.11M Sell
5,043
-80
-2% -$16.6K 0.3% 110
2024
Q2
$1.01M Sell
5,123
-167
-3% -$34.5K 0.29% 108
2024
Q1
$1.14M Sell
5,290
-143
-3% -$30K 0.44% 75
2023
Q4
$1.14M Buy
+5,433
New +$1.16M 0.6% 61
2019
Q1
Sell
-11,014
Closed -$2.07M 318
2018
Q4
$2.07M Buy
+11,014
New +$2.03M 0.48% 68
2018
Q3
Sell
-6,404
Closed -$1.05M 319
2018
Q2
$1.05M Buy
6,404
+5,832
+1,020% +$953K 0.15% 189
2018
Q1
$93K Buy
+572
New +$91.1K 0.01% 358
2015
Q4
Sell
-71,298
Closed -$6.61M 333
2015
Q3
$6.61M Buy
+71,298
New +$6.78M 0.76% 16

Other funds holding CME

Convergence Investment Partners's CME Position: Q1 2025 in Review

Convergence Investment Partners sold out of CME Group (CME) in Q1 2025, closing a stake of 5,760 shares — an estimated $1.34M sold.

Convergence Investment Partners first reported a position in CME in Q3 2015 and held it in 9 quarters. The position peaked at $6.61M in Q3 2015. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Convergence Investment Partners reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
  • Convergence Investment Partners sold 5,760 CME Group shares in Q1 2025, an estimated $1.34M.
  • Convergence Investment Partners first reported a position in CME Group in Q3 2015 and held it in 9 quarters.
  • Convergence Investment Partners's CME Group position peaked at $6.61M in Q3 2015.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Convergence Investment Partners's 13F filing for Q1 2025, filed 6 May 2025.